About the brand
Devaksh Lifesciences Franchise
Franchise Quick Facts
| Brand Name | Devaksh Lifesciences |
|---|---|
| Industry / Business Category | Healthcare Products / Critical Care Pharmaceuticals |
| Founded Year | 2023 |
| Franchise Started Year | 2023 |
| Total Franchise Outlets | 50–100 |
| Estimated Investment | INR 10,000 – 50 K |
| Franchise Fee | Not specified |
| Royalty Fee | Not specified |
| Space Requirement | 100–200 Sq.ft |
| Staff Requirement | Retail and distribution personnel |
| Expected Payback Period | 1–2 Years |
1. What is Devaksh Lifesciences?
Devaksh Lifesciences is a pharmaceutical company specializing in ophthalmic, otic, and nasal healthcare products. It operates in the healthcare and medical products industry, producing safe and cost-effective medications for patients in India. The brand caters to retailers, healthcare providers, and distributors seeking critical care pharmaceutical solutions.
2. How the Business Works
Franchise outlets distribute Devaksh Lifesciences healthcare products to retailers, clinics, and end-users. Customers interact through retail counters, pharmacies, or wholesale networks. Daily operations include inventory management, order fulfillment, sales tracking, and quality checks. Revenue is generated from product sales and distribution margins.
3. Products or Services Offered
Primary Product Categories
| Ophthalmic Products | Eye drops for infections, allergies, dryness, and inflammation |
|---|---|
| Otic Products | Ear drops for infections, wax build-up, and inflammation |
| Nasal Healthcare Products | Nasal sprays and drops for sinus congestion and allergic rhinitis |
All products are manufactured under GMP and WHO-compliant standards, ensuring safety, sterility, and consistent efficacy.
4. How the Franchise Model Works
| Role of Franchise Partner | Distribute Devaksh Lifesciences products to retailers, clinics, and end-users |
|---|---|
| Responsibilities of Franchise Owner | Manage sales, maintain inventory, follow brand guidelines, and ensure product quality |
| Outlet Operation | Retail or small-scale distribution point with storage for healthcare products |
| Relationship with Franchisor | Franchisees receive guidance on product handling, marketing support, training, and distribution strategies |
5. Franchise Cost and Investment Overview
| Estimated Investment | INR 10,000 – 50 K for inventory, storage setup, and basic operations |
|---|---|
| Franchise Fee | Not specified |
| Setup Cost Components | Initial stock procurement, storage facilities, branding, and basic retail infrastructure |
| Royalty / Ongoing Fees | Not specified |
6. Space and Infrastructure Requirements
| Space Requirement | 100–200 Sq.ft for storage and sales operations |
|---|---|
| Preferred Locations | Urban, semi-urban, or near healthcare service providers |
| Equipment Needs | Shelving, refrigeration if needed, POS systems, and inventory management tools |
| Staffing Requirements | 1–2 personnel for operations and customer interactions |
7. Training and Franchise Support
| Operational Training | Product knowledge, handling, and storage |
|---|---|
| Store Setup Guidance | Layout and branding support |
| Marketing Support | Promotional materials and campaigns |
| Ongoing Assistance | Guidance for sales strategies and supply chain management |
8. Revenue Model and ROI Factors
| Revenue Streams | Distribution and retail sales of ophthalmic, otic, and nasal healthcare products |
|---|---|
| Customer Demand Patterns | Consistent demand from pharmacies, clinics, and healthcare professionals |
| Repeat Purchase Potential | High due to consumable nature of products and ongoing prescriptions |
| Operational Cost Considerations | Inventory replenishment, staffing, rent, and utilities |
| Expected Payback Period | 1–2 Years |
9. Brand History and Expansion
| Established Year | 2023 |
|---|---|
| Franchising Began | 2023 |
| Number of Franchise Outlets | 50–100 |
| Geographic Markets Served | Nationwide distribution across India |
| Expansion Plans | Grow franchise network, expand distribution to urban and semi-urban regions |
10. Key Advantages of the Franchise
- Low investment with potential for quick returns
- Access to critical care pharmaceutical products with established demand
- Support with product knowledge, marketing, and operational guidance
- High repeat purchase potential due to consumable nature
- Opportunity to work with a GMP and WHO-compliant brand
11. Who Should Consider This Franchise
- Entrepreneurs seeking pharmaceutical or healthcare retail/distribution opportunities
- Individuals with interest in medical and critical care products
- Investors looking for low-cost entry into a regulated healthcare sector
- Existing pharmacy or distribution businesses aiming to expand product portfolio
Similar Franchise Opportunities
- Reliance Health Care – Pharmaceuticals distribution and retail
- MedPlus – Pharmacy and healthcare product retail
- Apollo Pharmacy – Nationwide pharmacy network
- 1mg Store – Health and wellness product distribution
- Himalaya Drug Company – Ayurvedic and pharmaceutical product distribution
Devaksh Lifesciences offers a low-investment entry into the pharmaceutical distribution sector, leveraging a GMP/WHO-compliant product range and a growing franchise network across India.
Investment and financials
Investor fit profile
Franchise support
Brand strength
Forefind rank history
Licences and compliance
Frequently asked questions
Investment ranges from INR 10,000 to 50 K, covering initial stock and setup requirements.
Franchisees distribute ophthalmic, otic, and nasal healthcare products to retail outlets, pharmacies, and clinics.
A space of 100–200 Sq.ft is adequate for storage, inventory, and operational management.
The expected payback period is approximately 1–2 years, depending on sales volume and market reach.
Prospective franchisees can contact Devaksh Lifesciences for details on inventory setup, training, and operational guidelines. ## Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.
